Research Papers

25 of 12945 papers

CSV Excel
Quick filters: Open Data Open Code Pre-registered Funding Declared COI Declared Open Access Clear Filters
FLT3 Mutated Acute Myeloid Leukemia after CD19 CAR-t Cells.
Galli E; Frioni F; Malara T; Attardi E; Bellesi S; Hohaus S; Sica S; Sorà F; Chiusolo P.
Mediterr J Hematol Infect Dis (Unknown)
Published: 2024
2/6 Transparent
How the Hemostasis Laboratory Can Help Clinicians to Manage Patients on Oral Anticoagulants.
Tripodi A; Clerici M; Scalambrino E; Agosti P; Bucciarelli P; Peyvandi F.
Mediterr J Hematol Infect Dis (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
CAR-T Cell Therapy for T-Cell Malignancies.
Testa U; Chiusolo P; Pelosi E; Castelli G; Leone G.
Unknown Journal
Published: 2024
2/6 Transparent
Suppression of A-to-I RNA-editing enzyme ADAR1 sensitizes hepatocellular carcinoma cells to oxidative stress through re…
Wang H; Wei X; Liu L; Zhang J; Li H.
Exp Hematol Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Reducing and controlling metabolic active tumor volume prior to CAR T-cell infusion can improve survival outcomes in pa…
Keijzer K; de Boer JW; van Doesum JA; Noordzij W; Huls GA; van Dijk LV; van Meerten T; Niezink AGH.
Unknown Journal
Published: 2024
4/6 Transparent
Code Funding Declared
Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study.
Mohan M; Monge J; Shah N; Luan D; Forsberg M; Bhatlapenumarthi V; Balev M; Patwari A; Cheruvalath H; Bhutani D; Thanendrarajan S; Dhakal B; Zangari M; Al-Hadidi S; Cooper D; Lentzsch S; van Rhee F; D'Souza A; Szabo A; Schinke C; Chakraborty R.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
The multi-CDK inhibitor dinaciclib reverses bromo- and extra-terminal domain (BET) inhibitor resistance in acute myeloi…
Marr AR; Halpin M; Corbin DL; Asemelash Y; Sher S; Gordon BK; Whipp EC; Mitchell S; Harrington BK; Orwick S; Benrashid S; Goettl VM; Yildiz V; Mitchell AD; Cahn O; Mims AS; Larkin KTM; Long M; Blachly J; Woyach JA; Lapalombella R; Grieselhuber NR.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Ibrutinib-Associated Leukocytoclastic Vasculitis in a Patient with Chronic Lymphocytic Leukemia.
Kaya A; Aras İ; Özkan Kurtgöz P; Çakıroğlu U.
Turk J Haematol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Drug conjugates for the treatment of lung cancer: from drug discovery to clinical practice.
Zhou L; Lu Y; Liu W; Wang S; Wang L; Zheng P; Zi G; Liu H; Liu W; Wei S.
Exp Hematol Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
FFAR2 expressing myeloid-derived suppressor cells drive cancer immunoevasion.
Zhao Z; Qin J; Qian Y; Huang C; Liu X; Wang N; Li L; Chao Y; Tan B; Zhang N; Qian M; Li D; Liu M; Du B.
J Hematol Oncol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Cirrhotic-extracellular matrix attenuates aPD-1 treatment response by initiating immunosuppressive neutrophil extracell…
Shen XT; Xie SZ; Zheng X; Zou TT; Hu BY; Xu J; Liu L; Xu YF; Wang XF; Wang H; Wang S; Zhu L; Yu KK; Zhu WW; Lu L; Zhang JB; Chen JH; Dong QZ; Yang LY; Qin LX.
Exp Hematol Oncol (Unknown)
Published: 2024
4/6 Transparent
Data Funding Declared
Interferons in the treatment of myeloproliferative neoplasms.
Vachhani P; Mascarenhas J; Bose P; Hobbs G; Yacoub A; Palmer JM; Gerds AT; Masarova L; Kuykendall AT; Rampal RK; Mesa R; Verstovsek S.
Ther Adv Hematol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Update on the management of relapsed/refractory chronic lymphocytic leukemia.
Bennett R; Seymour JF.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Immature Platelet Fraction and Clinical Outcomes in Patients Undergoing Transcatheter Aortic Valve Implantation.
Oppenheim L; Loutati R; Marmor D; Perel N; Tabi M; Taha L; Dvir D; Shuvy M; Jubeh R; Glikson M; Asher E.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Disseminated Intravascular Coagulation in Acute Promyelocytic Leukemia Patients: A Retrospective Analysis of Outcomes a…
Patel R; Patel D; Patel M; Ohemeng-Dapaah J; Onyechi A; Patel Z; Yang C; Shaikh S.
Turk J Haematol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Post-transplant cyclophosphamide versus anti-thymocyte globulin after reduced intensity peripheral blood allogeneic cel…
Brissot E; Labopin M; Labussière H; Fossard G; Chevallier P; Guillaume T; Yakoub-Agha I; Srour M; Bulabois CE; Huynh A; Chantepie S; Menard AL; Rubio MT; Ceballos P; Dulery R; Furst S; Malard F; Blaise D; Mohty M.
Unknown Journal
Published: 2024
4/6 Transparent
Registered Funding Declared
Blockade of the lncRNA-DOT1L-LAMP5 axis enhances autophagy and promotes degradation of MLL fusion proteins.
Chen TQ; Huang HJ; Zhu SX; Chen XT; Pu KJ; Wang D; An Y; Lian JY; Sun YM; Chen YQ; Wang WT.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
The effectiveness and safety of octocog alfa in patients with hemophilia A: up to 7-year follow-up of the real-world AH…
Ozelo MC; Hermans C; Carcao M; Guillet B; Gu J; Guerra R; Tang L; Khair K.
Unknown Journal
Published: 2024
4/6 Transparent
Registered Funding Declared
The UBE2J2/UBE2K-MARCH5 ubiquitination machinery regulates apoptosis in response to venetoclax in acute myeloid leukemi…
Lin S; Schneider C; Su AH; Alexe G; Root DE; Stegmaier K.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
When idiopathic multicentric Castleman disease meets COVID-19: a multicenter retrospective study from China.
Liu Y; Yin X; Xu D; Lv Y; Zhu L; Yang M; Yao Q; Jin J; Huang L; Meng H; You L.
Ther Adv Hematol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Ruxolitinib for the Treatment of Refractory Idiopathic Multicentric Castleman Disease: A Case Report
Gao YH; Duan MH; Li J; Zhang L.
Turk J Haematol (Unknown)
Published: 2024
3/6 Transparent
Funding Declared
Association of inherited thrombophilia mutations and their combinations among palestinian women with unexplained recurr…
Najjar AA; Hassouna I; Srour MA; Ibrahim HM; Assi RY; Abd El Latif HM.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
SERPINC1 c.1247dupC: a novel SERPINC1 gene mutation associated with familial thrombosis results in a secretion defect a…
Ruf M; Cunningham S; Wandersee A; Brox R; Achenbach S; Strobel J; Hackstein H; Schneider S.
Unknown Journal
Published: 2024
4/6 Transparent
Data Funding Declared
IL-15-secreting CAR natural killer cells directed toward the pan-cancer target CD70 eliminate both cancer cells and can…
Van den Eynde A; Gehrcken L; Verhezen T; Lau HW; Hermans C; Lambrechts H; Flieswasser T; Quatannens D; Roex G; Zwaenepoel K; Marcq E; Joye P; Cardenas De La Hoz E; Deben C; Gasparini A; Montay-Gruel P; Le Compte M; Lion E; Lardon F; Van Laere S; Siozopoulou V; Campillo-Davo D; De Waele J; Pauwels P; Jacobs J; Smits E; Van Audenaerde JRM.
Unknown Journal
Published: 2024
3/6 Transparent
Funding Declared
Differential clinical impact of letermovir prophylaxis according to graft sources: a KSGCT multicenter retrospective an…
Toya T; Mizuno K; Sakurai M; Kato J; Mori T; Doki N; Masuda S; Aotsuka N; Tsukamoto S; Sakaida E; Nakajima Y; Fujisawa S; Machida S; Aoyama Y; Yokoyama H; Shono K; Hatta Y; Usuki K; Kataoka K; Kanda Y.
Blood Adv (Unknown)
Published: 2024
3/6 Transparent
Funding Declared